Trial intelligence / Profile preview

Donepezil for Prevention of Postoperative Delirium

NCT00220896Phase 4Completed

Sponsor
Technical University of Munich
Start
Jan 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in delirium comparing Donepezil with Placebo (2 arms). Primary endpoint: Incidence of delirium at 49 days. Started Jan 2006; status: completed.

02

Drugs

donepezil
03

Conditions

delirium

Beyond the preview

Go deeper on NCT00220896.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00220896.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call